United Kingdom Prospective Diabetes Study 24: A 6-Year, Randomized, Controlled Trial Comparing Sulfonylurea, Insulin, and Metformin Therapy in Patients with Newly Diagnosed Type 2 Diabetes That Could Not Be Controlled with Diet Therapy

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Annals of Internal Medicine

• Publication date

  Unknown publication date

• Fields of study

  Not labeled

• Identifiers
  DOI 10.7326/0003-4819-128-3-199802010-00001
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• UKPDS 25: autoantibodies to islet-cell cytoplasm and glutamic acid decarboxylase for prediction of insulin requirement in type 2 diabetes. UK Prospective Diabetes Study Group.

  1997cited by this paper
• United Kingdom prospective diabetes study (UKPDS) 13: relative efficacy of randomly allocated diet, sulphonylurea, insulin, or metformin in patients with newly diagnosed non-insulin dependent diabetes followed for three years

  1995cited by this paper
• UK Prospective Diabetes Study (UKPDS) XI: Biochemical Risk Factors in Type 2 Diabetic Patients at Diagnosis Compared with Age‐matched Normal Subjects

  1994cited by this paper
• Undiagnosed NIDDM: Clinical and Public Health Issues

  1993cited by this paper
• Oral Hypoglycaemic Agents: The First Thirty Years

  1992cited by this paper
• Understanding "insulin resistance": both glucose resistance and insulin resistance are required to model human diabetes.

  1991cited by this paper
• Characteristics of non-insulin-dependent diabetic patients with secondary failure to oral antidiabetic therapy.

  1989cited by this paper
• The Achilles heel of the University Group Diabetes Program.

  1980cited by this paper

• Efficacy and safety of imeglimin add‐on to DPP‐4 inhibitor therapy in Japanese patients with type 2 diabetes mellitus: An interim analysis of the randomised, double‐blind FAMILIAR trial

  2025cites this paper
• Pharmacologic Glycemic Management of Type 2 Diabetes in Adults---2024 Update.

  2024cites this paper
• Current type 2 diabetes guidelines: Individualized treatment and how to make the most of metformin

  2024cites this paper
• Therapeutic patient education programs on diabetes in sub-Saharan Africa: A systematic review

  2024cites this paper
• The antioxidant, antidiabetic, and antihyperlipidemic effects of the polyphenolic extract from Salvia blancoana subsp. mesatlantica on induced diabetes in rats

  2024cites this paper
• Role of metabolic surgery in remission of type 2 diabetes mellitus in patients with obesity

  2023cites this paper
• Real-World Efficacy of Glucagon-like Peptide-1 (GLP-1) Receptor Agonist, Dulaglutide, on Metabolic Parameters in Japanese Patients with Type 2 Diabetes: A Retrospective Longitudinal Study

  2023cites this paper
• Attitudes of primary care physicians towards insulin initiation in people with type 2 diabetes in Bahrain

  2022cites this paper
• Körperliche und psychische Folgeerkrankungen bei Diabetes mellitus

  2022cites this paper
• Dietary Fiber Intake Is Related to Skeletal Muscle Mass, Body Fat Mass, and Muscle-to-Fat Ratio Among People With Type 2 Diabetes: A Cross-Sectional Study

  2022cites this paper
• Ramadan fasting and diabetes, latest evidence and technological advancements: 2021 update

  2021cites this paper
• Choosing Medications for Type 2 Diabetes – What Weighting Should Be Given to Cardiovascular Risk Reduction?

  2021cites this paper
• Risks of fasting during Ramadan: Cardiovascular, Cerebrovascular and Renal complications

  2021cites this paper
• Metabolic Control and Determinants Among HIV-Infected Type 2 Diabetes Mellitus Patients Attending a Tertiary Clinic in Botswana Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy

  2021cites this paper
• Bioactive Components of Salvia and Their Potential Antidiabetic Properties: A Review

  2021cites this paper
• Evolution in Overcoming Barriers in Management of Diabetes: Hypoglycemia

  2021cites this paper
• Prevalence and incidence of micro- and macro-vascular complications in a diabetic population of Bangladesh: a retrospective cohort study

  2021cites this paper
• The Aging Vasculature: Glucose Tolerance, Hypoglycemia and the Role of the Serum Response Factor

  2021cites this paper
• Metabolic Control and Determinants Among HIV-Infected Type 2 Diabetes Mellitus Patients Attending a Tertiary Clinic in Botswana Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy

  2021cites this paper
• Ramadan fasting and diabetes, latest evidence and technological advancements: 2021 update

  2021cites this paper
• A Review on Metformin: Clinical Significance and Side Effects

  2021cites this paper
• Impacts of early insulin treatment vs glimepiride in diabetic patients with background metformin therapy

  2021cites this paper
• The Association Between Metformin Treatment and Outcomes in Type 2 Diabetes Mellitus Patients With Heart Failure With Preserved Ejection Fraction: A Retrospective Study

  2021cites this paper
• Personalized diabetes management: what do patients with diabetes mellitus prefer? A discrete choice experiment

  2021cites this paper
• Driver versus navigator causation in biology: the case of insulin and fasting glucose

  2020cites this paper
• Oral insulin: an update.

  2020cites this paper
• Effect of diabetes self-management education on glycemic control in Latino adults with type 2 diabetes: A systematic review and meta-analysis.

  2020cites this paper
• Adolescent Nutrition: Assuring the Needs of Emerging Adults

  2020cites this paper
• Pioglitazone Exposure Reduced the Risk of All-Cause Mortality in Insulin-Treated Patients with Type 2 Diabetes Mellitus.

  2020cites this paper
• Hypoglycemia Induces Mitochondrial Reactive Oxygen Species Production Through Increased Fatty Acid Oxidation and Promotes Retinal Vascular Permeability in Diabetic Mice

  2020cites this paper
• Metabolic Control and Determinants Among HIV-Infected Type 2 Diabetes Mellitus Patients Attending a Tertiary Clinic in Botswana

  2020cites this paper
• Japanese Clinical Practice Guideline for Diabetes 2019

  2020cites this paper
• Type II Diabetes Mellitus

  2020cites this paper
• Japanese Clinical Practice Guideline for Diabetes 2019

  2020cites this paper
• Hypoglycaemia and its management in primary care setting

  2020cites this paper
• Severe hypoglycemia as a preventable risk factor for cardiovascular disease in patients with type 2 diabetes mellitus

  2020cites this paper
• Fasting insulin levels correlate with the frequency of hypoglycemic events in people with type 2 diabetes on treatment with sulfonylureas: A pilot study

  2020cites this paper
• Spotlight on experiences of medicine unavailability: access to medicines challenges for NCDs and NTDs - the contrasting cases of insulin and praziquantel

  2020cites this paper
• Long-term outcomes of adding alpha-glucosidase inhibitors in insulin-treated patients with type 2 diabetes

  2020cites this paper
• HSOA Journal of Diabetes & Metabolic Disorders The Side Effects of Metformin - A Review

  2019cites this paper
• The Effectiveness of Registered Dietitians in Diabetes Case Management

  2019cites this paper
• All-cause mortality of insulin plus dipeptidyl peptidase-4 inhibitors in persons with type 2 diabetes

  2019cites this paper
• Diabetes Education Impact on Hypoglycemia Outcomes: A Systematic Review of Evidence and Gaps in the Literature

  2019cites this paper
• Endocrine Pharmacology

  2019cites this paper
• Understanding the glucoregulatory mechanisms of metformin in type 2 diabetes mellitus

  2019cites this paper
• Does insulin signalling decide glucose levels in the fasting steady state?

  2019cites this paper
• Efficacy and safety of empagliflozin as add‐on to insulin in Japanese patients with type 2 diabetes: A randomized, double‐blind, placebo‐controlled trial

  2019cites this paper
• Research progress on the relationship between DJ-1 protein and diabetes DJ-1 蛋白与糖尿病的关系研究进展

  2018cites this paper
• Cardiovascular outcomes of dipeptidyl peptidase-4 inhibitors in patients with type 2 diabetes on insulin therapy.

  2018cites this paper
• Pharmacologic Glycemic Management of Type 2 Diabetes in Adults.

  2018cites this paper
• High Glucose-Mediated Tyrosine Nitration of PI3-Kinase: A Molecular Switch of Survival and Apoptosis in Endothelial Cells

  2018cites this paper
• Relationship between serum adipsin and the first phase of glucose‐stimulated insulin secretion in individuals with different glucose tolerance

  2018cites this paper
• Pharmacokinetics of metformin in patients with gastrointestinal intolerance

  2018cites this paper
• Metformin monotherapy for adults with type 2 diabetes mellitus.

  2018cites this paper
• The Metformin Paradox.

  2018cites this paper
• Möglichkeiten moderner Diabetestechnologie

  2018cites this paper
• Mobile Diabetes Intervention Study of Patient Engagement and Impact on Blood Glucose: Mixed Methods Analysis

  2018cites this paper
• Japanese Clinical Practice Guideline for Diabetes 2016

  2018cites this paper
• Choosing the Best Oral Diabetic Agents in T2 Diabetes Mellitus-Physicians Challenge

  2018cites this paper
• Projet SPICES : sélection parmi 5 recommandations de bonne pratique pour la prévention des maladies cardiovasculaires via les procédures AGREE II et ADAPTE. Identification des références bibliographiques des recommandations internationales, « 2013 AHA/ACC/TOS. Guideline for the Management of Overwei

  2018cites this paper
• Systemic effects of periodontitis treatment in patients with type 2 diabetes: a 12 month, single-centre, investigator-masked, randomised trial.

  2018cites this paper
• Japanese Clinical Practice Guideline for Diabetes 2016

  2018cites this paper
• Effectiveness and safety of insulin glargine plus glimepiride after 6 months of treatment among patients with type 2 diabetes mellitus who failed premixed insulin: An observational study conducted in Egypt

  2017cites this paper
• Estimation of insulin secretion, glucose uptake by tissues, and liver handling of glucose using a mathematical model of glucose-insulin homeostasis in lean and obese mice

  2017cites this paper
• Weight change after initiation of oral hypoglycemic monotherapy for diabetes predicts 5-year mortality: An observational study.

  2017cites this paper
• Relationship between HLA haplotype and BMI change in Japanese slowly progressive type 1 diabetes patients.

  2017cites this paper
• Retrospective analysis of primary and sequential care of type 2 diabetes patients in Taiwan

  2017cites this paper
• Oral Insulin Delivery in a Physiologic Context: Review

  2017cites this paper
• Cardiovascular safety of non-insulin pharmacotherapy for type 2 diabetes

  2017cites this paper
• Efficacy and Safety of Basal-Supported Prandial GLP-1 Receptor Agonist Therapy

  2017cites this paper
• Cardiovascular safety of oral antidiabetic therapy in type 2 diabetes mellitus- review article

  2017cites this paper
• Efficacy and safety of insulin in type 2 diabetes: meta-analysis of randomised controlled trials

  2016cites this paper
• The importance of the multidisciplinary team for the management of complex obesity in patients with diabetes

  2016cites this paper
• Addition of sulphonylurea to metformin does not relevantly change body weight: a prospective observational cohort study (ZODIAC‐39)

  2016cites this paper
• Diabetes Medications as Monotherapy or Metformin-Based Combination Therapy for Type 2 Diabetes

  2016cites this paper
• Efficacy and safety of canagliflozin in combination with insulin: a double-blind, randomized, placebo-controlled study in Japanese patients with type 2 diabetes mellitus

  2016cites this paper
• S.A.M. and Breast Cancer—Focus on Metformin and Other Integrative Metformin-Mimic Medicines: The Real “Natural” Options

  2016cites this paper
• PRESCRIBING PATTERN OF ANTIDIABETIC DRUGS IN TYPE-2 DIABETIC PATIENTS

  2016cites this paper
• Combination therapy of SGLT2 inhibitors with incretin-based therapies for the treatment of type 2 diabetes mellitus: Effects and mechanisms of action

  2016cites this paper
• Efficacy and Safety of the SGLT2 Inhibitor Luseogliflozin in Japanese Patients With Type 2 Diabetes Mellitus Stratified According to Baseline Body Mass Index: Pooled Analysis of Data From 52-Week Phase III Trials.

  2016cites this paper
• Pharmacogenetics and individual responses to treatment of hyperglycemia in type 2 diabetes.

  2015cites this paper
• Evidence-based practice guideline for the treatment for diabetes in Japan 2013

  2015cites this paper
• Control of cardiovascular risk factors in revascularized patients with diabetes: a subanalysis of the ICP-Bypass study.

  2015cites this paper
• Prescribing pattern of antidiabetic drugs in urban population of Hyderabad

  2015cites this paper
• Control de factores de riesgo cardiovascular en pacientes diabéticos revascularizados: un subanálisis del estudio ICP-Bypass

  2015cites this paper
• Hyp-O-besity: Unmet Challenge in Management of Type 2 Diabetes Mellitus and Cardiovascular Risk

  2015cites this paper
• Oral antihyperglycemic treatment options for type 2 diabetes mellitus.

  2015cites this paper
• Breaking down barriers to initiating insulin: Insulin prescription pad.

  2015cites this paper
• Safety, efficacy, and early clinical experience of insulin degludec in Japanese people with diabetes mellitus: A first-year report from Japan

  2015cites this paper
• Place of sulfonylureas in the management of type 2 diabetes mellitus in South Asia: A consensus statement

  2015cites this paper
• Differential Cardiovascular Outcomes after Dipeptidyl Peptidase-4 Inhibitor, Sulfonylurea, and Pioglitazone Therapy, All in Combination with Metformin, for Type 2 Diabetes: A Population-Based Cohort Study

  2015cites this paper
• Are insulin analogues an unavoidable necessity for the treatment of type 2 diabetes in developing countries? The case of Jordan.

  2015cites this paper
• A randomized controlled trial of liraglutide versus insulin detemir plus sitagliptin: Effective switch from intensive insulin therapy to the once‐daily injection in patients with well‐controlled type 2 diabetes

  2015cites this paper
• Management Guidelines for Children with Thyroid Nodules and Differentiated Thyroid Cancer

  2015cites this paper
• The effects of Metformin Use on Body Mass Index: A Prospective Study

  2015cites this paper
• Cardiovascular Risk in Diabetes Mellitus: Complication of the Disease or of Antihyperglycemic Medications

  2015cites this paper
• Weight Gain on Glucose-Lowering Agents

  2014cites this paper
• Glucose control: Non-insulin therapies

  2014cites this paper
• Economic Impact of Therapeutic Choices: The Case of Incretins

  2014cites this paper
• A Combined Analysis of 48 Type 2 Diabetes Genetic Risk Variants Shows No Discriminative Value to Predict Time to First Prescription of a Glucose Lowering Drug in Danish Patients with Screen Detected Type 2 Diabetes

  2014cites this paper